In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Charlotte Elwood was diagnosed with a rare ovarian cancer in 1997 and given six months to live. She received multiple ...

The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...

Cancer and metabolic diseases, such as obesity, diabetes, and metabolic syndrome, are increasingly recognized as ...

Circadian rhythms are endogenous time-keeping mechanisms that regulate physiological processes in response to external light-dark cycles.

Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer ...

Immunotherapy has emerged as one of the major options for cancer treatment in the past decade. With the successful application of immune checkpoint inhibitors and the introduction of immune regulatory ...

GLP-1 RA use was associated with significantly lower risk of certain cancers compared with metformin use and insulin use.

A recent study suggests that GLP-1 receptor agonists (GLP-1RAs) may lower the risk of hematologic cancers, including leukemia ...

Mar. 18, 2025 — Researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor ...

Cancer researchers at Children's Medical Research Institute have discovered an "unexpected mechanism" that our cells use to avoid cancer.